Skip to content

Effect of a lateral nerve of the thigh block on postoperative pain after total hip replacement surgery: a clinical radomised trial.

Effect of a lateral nerve of the thigh block on postoperative pain after total hip replacement surgery: a clinical radomised trial.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2013-004501-12-DK
Enrollment
Unknown
Registered
2013-12-10
Start date
2013-12-20
Completion date
Unknown
Last updated
2016-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain after total hip replacement surgery MedDRA version: 17.0 Level: LLT Classification code 10044088 Term: Total hip replacement System Organ Class: 100000004865 MedDRA version: 17.0 Level: LLT Classification code 10054711 Term: Postoperative pain System Organ Class: 100000004863

Interventions

Trade Name: Naropin Pharmaceutical Form: Solution for injection INN or Proposed INN: Naropin Other descriptive name: ROPIVACAINE HYDROCHLORIDE Concentration unit: mg/l milligram(s)/litre Concentration

Sponsors

Departement of Anesthesiology, Næstved Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All patients to primary total hip replacement. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 20 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 80

Exclusion criteria

Exclusion criteria: Patients undergoing general anesthesia Allergy to local anesthetics of the amide type. Revision surgery. Bilateral surgery. Chronic pain patient Women in the fertile age

Design outcomes

Primary

MeasureTime frame
Main Objective: Investigation of the influence of a lateral cutaneus nerve of the thigh block on postoperative pain after total hip replacement surgery with visual analog scale. Total oxynorm dose 1. day after surgery.;Secondary Objective: Total oxynorm dose under the complete admission. Time from operation to the first dose of oxynorm. Reduced motoric function under early mobilisation (CAS-score). Time for the first mobilisation. Total admissiontime.;Primary end point(s): 1. Visual analog pain scale of the patients under movement (elevetion of the operated leg 30 degree above bed or similar.;Timepoint(s) of evaluation of this end point: 1. VAS score at time 4 hours after admission of the block.

Secondary

MeasureTime frame
Secondary end point(s): 1. Total oxynorm administration under the 1. day of admission 2. VAS score 3. Total oxynorm administratin under the whole admission 4 Time from the admission of the block to the first administration of oxynorm 5. Validation of the motor block under the early mobilisation 6. Time for the first mobilisation 6. Total admissiontime to the ward;Timepoint(s) of evaluation of this end point: 1. After discharge of the patient 2. Time: 0, 1, 2, 4, 8, 12 and 24 hours after admission of the block 3. After discharge of the patient 4. After discharge of the patient 5. After the first mobilisation of the patient 6. After the first mobilisation of the patient 7. After discharge of the patient

Countries

Denmark

Contacts

Public ContactOffice

Departement of Anesthesiology, Næstved Hospital

anaestesisekretariat@regionsjaelland.dk+4556514002

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Mar 13, 2026